Company intelligence
Biognosys
Omics made accessible
About Biognosys
The Biognosys Group brings together the Bruker Corporation affiliates Biognosys, biocrates, and PreOmics to deliver integrated solutions across proteomics, metabolomics, and lipidomics. The Group enables seamlessly connected mass spectrometry workflows, making advanced multiomics technologies accessible to laboratories worldwide. Its ecosystem spans high quality consumables, kits, software, and contract research services. Committed to a vendor-agnostic approach, the Biognosys Group supports open collaboration and broad compatibility across leading mass spectrometry platforms. All solutions are modular by design, allowing customers to choose the level of support that best fits their needs, from ready to use kits and software to guided implementation, or fully integrated end to end CRO services.
Verified activity
Signals from Biognosys
4 published signals
Presence & Recognition
Biognosys attended the Discovering Precision Medicines meeting in Belfast at ELRIG.
Reported by Kirsty Holden PhD
Presence & Recognition
Biognosys attended the IMSC 2026 conference and presented research on proteomics, metabolomics, and computational analysis at the Biognosys Group booth.
Reported by Biognosys
Presence & Recognition
Biognosys is attending the SPS 2026 poster presentation by Adam Hughes on Plasma Proteomics at the Umeå event from 16-18 September.
Reported by Biognosys
Presence & Recognition
Biognosys is attending APMRS 2026 hosted by APMA Austria and the Universität Graz, Austria.
Reported by Biognosys